Brief: Alimera Sciences Reports Fourth Quarter And 2020 Results
24/02/2021 21:42
Feb 24 (Reuters) - Alimera Sciences Inc ALIM.O :
* ALIMERA SCIENCES REPORTS FOURTH QUARTER AND 2020 RESULTS
* Q4 LOSS PER SHARE $0.18
* Q4 REVENUE $13.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$13.4
MILLION
* Q4 EARNINGS PER SHARE ESTIMATE $-0.10 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX3t2fXR
Further company coverage: ALIM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger